Mast cell: Insight into remodeling a tumor microenvironment

Cancer and Metastasis Reviews

Volumn 30, Issue 2, 2011, Pages 177-184

  Liu, Jing ^a   Zhang, Yi ^a   Zhao, Jie ^a   Yang, Zhuoshun ^a   Li, Dapeng ^a   Katirai, Foad ^a   Huang, Bo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Mast cell; Mediators; Microparticles; Stromal cells; Tumor microenvironment

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD39 ANTIGEN; COMPLEMENT RECEPTOR; CYCLOOXYGENASE 2; FC RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEPARIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STEM CELL FACTOR; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE;

CANCER CELL; CANCER INVASION; CELL INTERACTION; CELL MIGRATION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTE MICROPARTICLE; MAST CELL; MAST CELL DEGRANULATION; METASTASIS; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TUMOR MICROENVIRONMENT; TUMOR MICROENVIRONMENT REMODELING; ANIMAL; BIOLOGICAL MODEL; IMMUNOLOGY; METABOLISM; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; HUMANS; MAST CELLS; MODELS, IMMUNOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 79961015886     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9276-1     Document Type: Review

References (58)

1. Metcalfe, D. D., Baram, D., & Mekori, Y. A. (1997). Mast cells. Physiological Reviews, 77, 1033-1079. (Pubitemid 27459579)
2. Heib, V., Becker, M., Taube, C., & Stassen, M. (2008). Advances in the understanding of mast cell function. British Journal Haematology, 142, 683-694.
3. Bauer, O., & Razin, E. (2000). Mast Cell-Nerve Interactions. News in Physiological Sciences, 15, 213-218.
4. Weller, K., Foitzik, K., Paus, R., Syska, W., & Maurer, M. (2006). Mast cells are required for normal healing of skin wounds in mice. The FASEB Journal, 20, 2366-2368.
5. Hebda, P. A., Collins, M. A., & Tharp, M. D. (1993). Mast cell and myofibroblast in wound healing. Dermatologic Clinics, 11, 685-696. (Pubitemid 23313913)
6. Blair, R. J., Meng, H., Marchese, M. J., Ren, S., Schwartz, L. B., Tonnesen, M. G., et al. (1997). Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. The Journal of Clinical Investigation, 99, 2691-2700. (Pubitemid 27259816)
7. Williams, C. M., & Galli, S. J. (2000). The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. The Journal of Allergy and Clinical Immunology, 105, 847-859. (Pubitemid 30324391)
8. Benoist, C., & Mathis, D. (2002). Mast cells in autoimmune disease. Nature, 420, 875-878. (Pubitemid 36019641)
9. de Vries, V., Pino-Lagos, K., Elgueta, R., & Noelle, R. J. (2009). The enigmatic role of mast cells in dominant tolerance. Current Opinion in Organ Transplantation, 14, 332-337.
10. Sayed, B. A., Christy, A., Quirion, M. R., & Brown, M. A. (2008). The master switch: the role of mast cells in autoimmunity and tolerance. Annual Review of Immunology, 26, 705-739. (Pubitemid 351600390)
11. Palker, T. J., Dong, G., & Leitner, W. W. (2010). Mast cells in innate and adaptive immunity to infection. European Journal of Immunology, 40, 13-18.
12. Galli, S. J., Nakae, S., & Tsai, M. (2005). Mast cells in the development of adaptive immune responses. Nature Immunology, 6, 135-142. (Pubitemid 40268194)
13. Conti, P., Castellani, M. L., Kempuraj, D., Salini, V., Vecchiet, J., Tete, S., et al. (2007). Role of mast cells in tumor growth. Annals of Clinical and Laboratory Science, 37, 315-322. (Pubitemid 350105931)
14. Johansson, A., Rudolfsson, S., Hammarsten, P., Halin, S., Pietras, K., Jones, J., et al. (2010). Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy. The American Journal of Pathology, 177, 1031-1041.
15. Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008). The role of myeloid cells in the promotion of tumour angiogenesis. Nature Reviews. Cancer, 8, 618-631.
16. Mayani, H., Guilbert, L. J., & Janowska-Wieczorek, A. (1992). Biology of the hemopoietic microenvironment. European Journal of Haematology, 49, 225-233. (Pubitemid 23024284)
17. Siclari, V. A., Guise, T. A., & Chirgwin, J. M. (2006). Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer and Metastasis Reviews, 25, 621-633. (Pubitemid 46075000)
18. Noel, A., Jost, M., & Maquoi, E. (2008). Matrix metalloproteinases at cancer tumor-host interface. Seminars in Cell & Developmental Biology, 19, 52-60. (Pubitemid 350235981)
19. Hanna, E., Quick, J., & Libutti, S. K. (2009). The tumour microenvironment: a novel target for cancer therapy. Oral Diseases, 15, 8-17.
20. Huang, B., Lei, Z., Zhang, G. M., Li, D., Song, C., Li, B., et al. (2008). SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood, 112, 1269-1279.
21. Yang, Z., Zhang, B., Li, D., Lv, M., Huang, C., Shen, G. X., et al. (2010). Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model. PLoS ONE, 5, e8922.
22. Maltby, S., Khazaie, K., & McNagny, K. M. (2009). Mast cells in tumor growth: angiogenesis, tissue remodelling and immunemodulation. Biochimica et Biophysica Acta, 1796, 19-26.
23. Kinet, J. P. (1999). The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annual Review of Immunology, 17, 931-972.
24. Malbec, O., & Daeron, M. (2007). The mast cell IgG receptors and their roles in tissue inflammation. Immunological Reviews, 217, 206-221. (Pubitemid 46718144)
25. Marshall, J. S. (2004). Mast-cell responses to pathogens. Nature Reviews. Immunology, 4, 787-799. (Pubitemid 39336295)
26. Dawicki, W., & Marshall, J. S. (2007). New and emerging roles for mast cells in host defence. Current Opinion in Immunology, 19, 31-38. (Pubitemid 46073696)
27. Matsushima, H., Yamada, N., Matsue, H., & Shimada, S. (2004). TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. Journal of Immunology, 173, 531-541. (Pubitemid 38797381)
28. Varadaradjalou, S., Feger, F., Thieblemont, N., Hamouda, N. B., Pleau, J. M., Dy, M., et al. (2003). Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. European Journal of Immunology, 33, 899-906. (Pubitemid 36546677)
29. Piccinini, A. M., & Midwood, K. S. (2010). DAMPening Inflammation by Modulating TLR Signalling. Mediators of Inflammation, 2010.
30. Fischer, M., & Ehlers, M. (2008). Toll-like receptors in autoimmunity. Annals of the New York Academy of Sciences, 1143, 21- 34.
31. Sims, G. P., Rowe, D. C., Rietdijk, S. T., Herbst, R., & Coyle, A. J. (2010). HMGB1 and RAGE in inflammation and cancer. Annual Review of Immunology, 28, 367-388.
32. Lu, W. J., Lee, N. P., Fatima, S., & Luk, J. M. (2009). Heat shock proteins in cancer: signaling pathways, tumor markers and molecular targets in liver malignancy. Protein and Peptide Letters, 16, 508-516.
33. Smiley, S. T., King, J. A., & Hancock, W. W. (2001). Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. Journal of Immunology, 167, 2887-2894. (Pubitemid 32768923)
34. Tesniere, A., Panaretakis, T., Kepp, O., Apetoh, L., Ghiringhelli, F., Zitvogel, L., et al. (2008). Molecular characteristics of immunogenic cancer cell death. Cell Death and Differentiation, 15, 3-12. (Pubitemid 350286167)
35. Caughey, G. H. (2007). Mast cell tryptases and chymases in inflammation and host defense. Immunological Reviews, 217, 141-154. (Pubitemid 46718143)
36. Datta, Y. H., Romano, M., Jacobson, B. C., Golan, D. E., Serhan, C. N., & Ewenstein, B. M. (1995). Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells. Circulation, 92, 3304-3311.
37. Boyce, J. A. (2007). Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunological Reviews, 217, 168-185. (Pubitemid 46718145)
38. Mekori, Y. A., & Metcalfe, D. D. (1999). Mast cell-T cell interactions. The Journal of Allergy and Clinical Immunology, 104, 517-523. (Pubitemid 29451636)
39. Kim, B. G., Li, C., Qiao, W., Mamura, M., Kasprzak, B., Anver, M., et al. (2006). Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature, 441, 1015-1019. (Pubitemid 43980359)
40. Abraham, S. N., & St John, A. L. (2010). Mast cell-orchestrated immunity to pathogens. Nature Reviews. Immunology, 10, 440-452.
41. Josko, J., & Mazurek, M. (2004). Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Medical Science Monitor, 10, RA89-RA98. (Pubitemid 38525095)
42. Qian, B. Z., & Pollard, J. W. (2010). Macrophage diversity enhances tumor progression and metastasis. Cell, 141, 39-51.
43. Zou, W. (2005). Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Reviews. Cancer, 5, 263-274. (Pubitemid 40488632)
44. Gabrilovich, D. I., & Nagaraj, S. (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nature Reviews. Immunology, 9, 162-174.
45. Kitamura, Y., & Fujita, J. (1989). Regulation of mast cell differentiation. Bioessays, 10, 193-196.
46. Tsuji, K., Nakahata, T., Takagi, M., Kobayashi, T., Ishiguro, A., Kikuchi, T., et al. (1990). Effects of interleukin-3 and interleukin- 4 on the development of "connective tissue-type" mast cells: interleukin-3 supports their survival and interleukin-4 triggers and supports their proliferation synergistically with interleukin-3. Blood, 75, 421-427. (Pubitemid 20035273)
47. Zhang, W., Stoica, G., Tasca, S. I., Kelly, K. A., & Meininger, C. J. (2000). Modulation of tumor angiogenesis by stem cell factor. Cancer Research, 60, 6757-6762.
48. Finotto, S., Buerke, M., Lingnau, K., Schmitt, E., Galle, P. R., & Neurath, M. F. (2001). Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma. The Journal of Allergy and Clinical Immunology, 107, 279-286. (Pubitemid 32173905)
49. Hassan, H. T. (2009). c-Kit expression in human normal and malignant stem cells prognostic and therapeutic implications. Leukemia Research, 33, 5-10.
50. Kinet, J. P. (2007). The essential role of mast cells in orchestrating inflammation. Immunological Reviews, 217, 5-7.
51. Fossiez, F., Banchereau, J., Murray, R., Van, K. C., Garrone, P., & Lebecque, S. (1998). Interleukin-17. International Reviews of Immunology, 16, 541-551. (Pubitemid 28286184)
52. Sylvester, J., Liacini, A., Li, W. Q., & Zafarullah, M. (2004). Interleukin-17 signal transduction pathways implicated in inducing matrix metalloproteinase-3, -13 and aggrecanase-1 genes in articular chondrocytes. Cellular Signalling, 16, 469- 476. (Pubitemid 38058629)
53. Blatner, N. R., Bonertz, A., Beckhove, P., Cheon, E. C., Krantz, S. B., Strouch, M., et al. (2010). In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction. Proceedings of the National Academy of Sciences of the United States of America, 107, 6430-6435.
54. Strouch, M. J., Cheon, E. C., Salabat, M. R., Krantz, S. B., Gounaris, E., Melstrom, L. G., et al. (2010). Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clinical Cancer Research, 16, 2257-2265.
55. Melillo, R. M., Guarino, V., Avilla, E., Galdiero, M. R., Liotti, F., Prevete, N., et al. (2010). Mast cells have a protumorigenic role in human thyroid cancer. Oncogene, 29, 6203-6215.
56. Bode, A. P., Sandberg, H., Dombrose, F. A., & Lentz, B. R. (1985). Association of factor Vactivity with membranous vesicles released from human platelets: requirement for platelet stimulation. Thrombosis Research, 39, 49-61. (Pubitemid 15008440)
57. VanWijk, M. J., VanBavel, E., Sturk, A., & Nieuwland, R. (2003). Microparticles in cardiovascular diseases. Cardiovascular Research, 59, 277-287. (Pubitemid 37272022)
58. Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., & Ratajczak, M. Z. (2006). Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia, 20, 1487-1495. (Pubitemid 44264090)